Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.89 USD | +1.12% | +0.68% | -1.65% |
Capitalization | 11.92B 11.32B 10.53B 9.38B 16.78B 1,010B 18.53B 130B 48.44B 414B 44.78B 43.8B 1,791B | P/E ratio 2025 * |
62.5x | P/E ratio 2026 * | 48x |
---|---|---|---|---|---|
Enterprise value | 11.83B 11.24B 10.45B 9.31B 16.65B 1,003B 18.39B 129B 48.07B 411B 44.44B 43.47B 1,777B | EV / Sales 2025 * |
9.67x | EV / Sales 2026 * | 8.63x |
Free-Float |
98.96% | Yield 2025 * |
0.43% | Yield 2026 * | 0.44% |
Last Transcript: Bio-Techne Corporation
1 day | +1.12% | ||
1 week | +0.68% | ||
Current month | +0.70% | ||
1 month | -0.01% | ||
3 months | +6.71% | ||
6 months | -1.31% | ||
Current year | -1.65% |
Director | Title | Age | Since |
---|---|---|---|
Kim Kelderman
CEO | Chief Executive Officer | 57 | 31/01/2024 |
James Hippel
DFI | Director of Finance/CFO | 53 | 31/03/2014 |
David Clair
IRC | Investor Relations Contact | - | 30/09/2019 |
Manager | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 01/11/2012 | |
John Higgins
BRD | Director/Board Member | 54 | 18/05/2009 |
Roeland Nusse
BRD | Director/Board Member | 74 | 25/05/2010 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.93% | 1 M€ | -.--% | - | |
2.50% | 5 M€ | -1.80% | - | |
2.15% | 2 M€ | -.--% | ||
1.25% | 0 M€ | 0.00% | - | |
1.13% | 0 M€ | 0.00% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+1.12% | +0.68% | +16.22% | -35.17% | 11.92B | ||
+0.65% | -0.49% | +57.83% | -26.45% | 42.79B | ||
+1.29% | +0.86% | -6.06% | -22.78% | 36.41B | ||
-2.09% | +4.21% | +12.20% | -7.78% | 27.1B | ||
+0.71% | +0.78% | -19.55% | -19.34% | 17.58B | ||
+1.52% | -0.99% | +56.04% | +98.39% | 16.46B | ||
-2.23% | -4.06% | -47.88% | -84.31% | 16.39B | ||
+2.08% | +2.17% | +23.89% | +68.95% | 10.52B | ||
+0.03% | -0.12% | -0.63% | -43.27% | 10.19B | ||
+1.11% | +0.05% | +2.28% | -20.46% | 9.62B | ||
Average | +0.47% | -0.22% | +9.44% | -9.22% | 19.9B | |
Weighted average by Cap. | +0.32% | -0.51% | +14.27% | -13.09% |
2025 * | 2026 * | |
---|---|---|
Net sales | 1.22B 1.16B 1.08B 962M 1.72B 104B 1.9B 13.37B 4.97B 42.51B 4.59B 4.49B 184B | 1.34B 1.27B 1.18B 1.05B 1.88B 113B 2.08B 14.62B 5.43B 46.48B 5.02B 4.91B 201B |
Net income | 198M 188M 175M 156M 278M 16.76B 307M 2.16B 804M 6.87B 743M 727M 29.71B | 261M 248M 231M 205M 368M 22.13B 406M 2.86B 1.06B 9.08B 981M 960M 39.23B |
Net Debt | -90.53M -85.97M -79.96M -71.2M -127M -7.67B -141M -990M -368M -3.15B -340M -333M -13.59B | -379M -360M -335M -298M -534M -32.15B -590M -4.15B -1.54B -13.19B -1.43B -1.39B -56.98B |
Date | Price | Change | Volume |
---|---|---|---|
04/12/24 | 75.89 $ | +1.12% | 571,306 |
03/12/24 | 75.05 $ | -1.28% | 595,596 |
02/12/24 | 76.02 $ | +0.88% | 922,632 |
29/11/24 | 75.36 $ | -0.03% | 464,410 |
27/11/24 | 75.38 $ | +0.68% | 557,025 |
Delayed Quote Nasdaq, December 04, 2024 at 09:00 pm
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- TECH Stock
MarketScreener is also available in this country: United States.
Switch edition